Catecholamine surrogates useful as .beta..sub.3 agonists

US5770615A · kind A · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Peter Cheng · Princeton, US
• Gregory S. Bisacchi · Lawrenceville, US
• Ashvinikumar V. Gavai · Princeton Junction, US
• Kathleen M. Poss · Lawrenceville, US
• Denis E. Ryono · Princeton, US
• Philip M. Sher · Plainsboro, US
• Chong-Qing Sun · Plainsboro, US
• William N. Washburn · Titusville, US

Key dates

• Filing date: Mar 28, 1997
• Grant date: Jun 23, 1998
• Expiry date: Mar 28, 2017

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F9/4056
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof. These compounds are beta three adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity and gastrointestinal diseases.